UNSPSC 51284601: Biapenem

This classification denotes a beta-lactam antibiotic with the molecular formula C15H18N4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YR5U3L9ZH1, chemically known as 6-(((4r,5s,6s)-2-carboxy-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-en-3-yl)thio)-6,7-dihydro-5h-pyrazolo(1,2-a)-s-triazol-4-ium hydroxide, inner salt but generally known as biapenem, which bears US NIH Compound Identifier 71339.

UNSPSC 51284601 Biapenem is a Commodity code for a specific beta-lactam antibiotic product. The recent state and local contract activity tagged under this code does not align with its pharmaceutical scope: the Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets (fluoroquinolones and tetracyclines, not beta-lactams), and Seminole County, Florida posted an IFB in June 2026 for Naloxone and drug deactivation systems (opioid antagonist and harm-reduction equipment). Neither opportunity involves biapenem procurement. The code shows little relevant recent activity under its stated pharmaceutical category.

State and local procurement offices appear to use this code infrequently or inconsistently for biapenem-specific solicitations. The issuing bodies in the available records—a state health department and a county government—represent typical buyers in the pharmaceutical and community health space, but the products they are actually soliciting fall outside the biapenem category. Geographic activity is limited to Illinois and Florida based on the recent postings. Without active, relevant biapenem-specific solicitations in the current market, business development professionals should monitor this code for future activity but expect limited near-term pursuit opportunities unless dedicated biapenem procurements emerge from state health departments, corrections systems, or public health emergency-response initiatives.